Comparison of Chromogenic and ELISA Functional C1 Inhibitor Tests in Diagnosing Hereditary Angioedema

Journal of Allergy and Clinical Immunology: In Practice

Volumn 3, Issue 2, 2015, Pages 200-205

  Li, H Henry ^a   Busse, Paula ^b   Lumry, William R ^c   Frazer Abel, Ashley ^d   Levy, Howard ^e   Steele, Tamara ^e   Dayno, Jeffrey ^e   Riedl, Marc ^f  

^a Institute for Asthma and Allergy   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Allergy And Asthma Research Associates Texas   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

^e ViroPharma Incorporated (part of the Shire Group of Companies)   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

C1 inhibitor; Complement testing; Hereditary angioedema

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ASSAY; CHILD; CHROMOGENIC METHOD; CLINICAL ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST DEGREE RELATIVE; HUMAN; INTERMETHOD COMPARISON; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; ANGIOEDEMAS, HEREDITARY; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANGIOEDEMAS, HEREDITARY; CHILD; CHILD, PRESCHOOL; COMPLEMENT C1 INHIBITOR PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84924241840     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.08.002     Document Type: Article

References (18)

1. Zuraw B.L. Clinical practice. Hereditary angioedema. NEngl J Med 2008, 359:1027-1036.
2. Lunn M.L., Santos C.B., Craig T.J. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?. Ann Allergy Asthma Immunol 2010, 104:211-214.
3. Roche O., Blanch A., Caballero T., Sastre N., Callejo D., Lopez-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 2005, 94:498-503.
4. Craig T., Aygoren-Pursun E., Bork K., Bowen T., Boysen H., Farkas H., et al. WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J 2012, 5:182-199.
5. Cicardi M., Aberer W., Banerji A., Bas M., Bernstein J.A., Bork K., et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 2014, 69:602-616.
6. Tarzi M.D., Hickey A., Forster T., Mohammadi M., Longhurst H.J. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema. Clin Exp Immunol 2007, 149:513-516.
7. Zuraw B.L., Sugimoto S., Curd J.G. The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. JAllergy Clin Immunol 1986, 78:1115-1120.
8. Frazer-Abel A., Giclas P.C. Update on laboratory tests for the diagnosis and differentiation of hereditary angioedema and acquired angioedema. Allergy Asthma Proc 2011, 32(Suppl 1):S17-21.
9. Wagenaar-Bos I.G., Drouet C., Aygoren-Pursun E., Bork K., Bucher C., Bygum A., et al. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. JImmunol Methods 2008, 338:14-20.
10. MicroVue Complement C1-Inhibitor Plus EIA Kit [package insert] 2012, Quidel Corp, San Diego, Calif.
11. Gompels M.M., Lock R.J. Laboratory testing for C1 inhibitor deficiency: a comparison of two approaches to C1 inhibitor function. Ann Clin Biochem 2007, 44:75-78.
12. Bork K., Meng G., Staubach P., Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006, 119:267-274.
13. Zuraw B.L., Kalfus I. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema. Am J Med 2012, 125:938. e1-7.
14. Gompels M.M., Lock R.J., Abinun M., Bethune C.A., Davies G., Grattan C., et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005, 139:379-394.
15. Bowen T., Cicardi M., Farkas H., Bork K., Longhurst H.J., Zuraw B., et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010, 6:24.
16. Cicardi M., Bork K., Caballero T., Craig T., Li H.H., Longhurst H., et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 2012, 67:147-157.
17. Lang D.M., Aberer W., Bernstein J.A., Chng H.H., Grumach A.S., Hide M., et al. International consensus on hereditary and acquired angioedema. Ann Allergy Asthma Immunol 2012, 109:395-402.
18. Zuraw B.L., Banerji A., Bernstein J.A., Busse P.J., Christiansen S.C., Davis-Lorton M., et al. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. JAllergy Clin Immunol Pract 2013, 1:458-467.